Plandai Biotechnology, Inc. announced that Dr. Ming Hu, Professor of Pharmaceutics at the University of Houston, has accepted a position on the company's scientific board. With Dr. Christina Nance from the Baylor School of Medicine, Dr. Hu is the co-investigator in a US government-funded clinical trial NCT01433289, to determine the safety, dosing and antiviral effects of epigallocatechin gallate (EGCG) in capsule form with HIV-1 infected, clinically stable individuals that are not on concomitant antiretroviral (ARV) Therapy.